Literature DB >> 7643989

Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease.

J P Sutton1, W Couldwell, M F Lew, L Mallory, S Grafton, C DeGiorgio, M Welsh, M L Apuzzo, J Ahmadi, C H Waters.   

Abstract

In a preliminary study, the effects of ventroposterior medial pallidotomy were evaluated in five patients with advanced Parkinson's disease in whom medical therapy had failed. The mean age was 67.0 +/- 5.6 years, and the mean Hoehn and Yahr stage when "off" was 3.9 +/- 1.3. Three patients received unilateral pallidotomies; two of these received another pallidotomy after 8 weeks. Two other patients received staged bilateral pallidotomies. No significant differences in overall function could be seen before and after the first surgical procedure. All three patients with peak-dose dyskinesias or dystonia had marked contralateral reduction in these symptoms. Ventroposterior medial pallidotomy can ameliorate peak-dose dyskinesias in patients with advanced Parkinson's disease. Overall function improvement is not remarkable.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7643989     DOI： 10.1227/00006123-199506000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


  10 in total

1.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Usefulness of pallidotomy in advanced Parkinson's disease.

Authors:  F Johansson; J Malm; E Nordh; M Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  Surgery for Parkinson's disease.

Authors:  J A Obeso; J Guridi; J A Obeso; M DeLong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

4.  Involuntary movements during thermolesion predict a better outcome after microelectrode guided posteroventral pallidotomy.

Authors:  M Merello; A Cammarota; O Betti; M I Nouzeilles; D Cerquetti; H Garcia; R Pikielny; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

Review 5.  Posteroventral medial pallidotomy in Parkinson's disease.

Authors:  A E Lang; J Duff; J A Saint-Cyr; L Trepanier; R E Gross; W Lombardi; E Montgomery; W Hutchinson; A M Lozano
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

6.  Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.

Authors:  P K Pal; A Samii; A Kishore; M Schulzer; E Mak; S Yardley; I M Turnbull; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

7.  Unilateral pallidotomy for Parkinson's disease: results after more than 1 year.

Authors:  A Schrag; M Samuel; E Caputo; T Scaravilli; M Troyer; C D Marsden; D G Thomas; A J Lees; D J Brooks; N P Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

8.  Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.

Authors:  P De Deurwaèrdere; M F Chesselet
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

9.  Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation.

Authors:  M Merello; S Starkstein; M I Nouzeilles; G Kuzis; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

10.  The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.

Authors:  M Lagière; S Navailles; L Mignon; A Roumegous; M-F Chesselet; P De Deurwaerdère
Journal:  Exp Brain Res       Date:  2013-03-28       Impact factor: 1.972
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.